Cardiometabolic benefits of a non-industrialized-type diet are linked to gut microbiome modulation
- PMID: 39855197
- DOI: 10.1016/j.cell.2024.12.034
Cardiometabolic benefits of a non-industrialized-type diet are linked to gut microbiome modulation
Abstract
Industrialization adversely affects the gut microbiome and predisposes individuals to chronic non-communicable diseases. We tested a microbiome restoration strategy comprising a diet that recapitulated key characteristics of non-industrialized dietary patterns (restore diet) and a bacterium rarely found in industrialized microbiomes (Limosilactobacillus reuteri) in a randomized controlled feeding trial in healthy Canadian adults. The restore diet, despite reducing gut microbiome diversity, enhanced the persistence of L. reuteri strain from rural Papua New Guinea (PB-W1) and redressed several microbiome features altered by industrialization. The diet also beneficially altered microbiota-derived plasma metabolites implicated in the etiology of chronic non-communicable diseases. Considerable cardiometabolic benefits were observed independently of L. reuteri administration, several of which could be accurately predicted by baseline and diet-responsive microbiome features. The findings suggest that a dietary intervention targeted toward restoring the gut microbiome can improve host-microbiome interactions that likely underpin chronic pathologies, which can guide dietary recommendations and the development of therapeutic and nutritional strategies.
Keywords: Limosilactobacillus reuteri; cardiometabolic health; chronic disease; diet; dietary intervention; fiber; gut microbiome; microbiome restoration; non-industrialized diet; nutrition.
Copyright © 2025 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests NiMe is a trademark of A.M.A and J.W. J.W. is an owner of a patent on Limosilactobacillus reuteri PB-W1 (NCIMB 42835), licensed to Novonesis A/S, of which income will be shared with the research institutes in Papua New Guinea and Canada that were involved in isolation and characterization of the strain. J.W. has further received honoraria and/or paid consultancy from PrecisionBiotics/Novonesis A/S. A.G. is an employee of Danone Specialized Nutrition. C.M.P. has previously received honoraria and/or paid consultancy from Abbott Nutrition, Nutricia, Nestlé Health Science, Pfizer, AMRA Medical, and Novo Nordisk unrelated to this work.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
